UC Berkeley researchers have developed a versatile platform of engineered non-living, semi-living, and living frameworks designed for programmable metal and molecule separation. By integrating metal-binding peptides (MBPs) with stimulus-responsive peptides (SRPs), these systems enable precise, on-demand capture and release of target compounds from complex liquid environments. The technology can be deployed as protein-based hydrogels, bacteriophage nanoparticles, or living bacterial systems, offering unmatched flexibility across industries.

When a delivered plasmid lacks exclusion genes during bacterial conjugation is a phenomenon known as lethal zygosis. The effect of this lethal zygosis is a severe bottleneck for genetic engineering. UC researchers have developed materials and methods that improve bacterial conjugation.  This replication incompetent vectors that include a nucleic acid sequence that can encode an exclusion polypeptide in a donor bacterial cell can protect a recipient bacterial cell from lethal zygosis.

The central hurdle in the clinical translation of mRNA-based medicine is the inherent toxicity of the delivery vehicle. Standard Lipid Nanoparticles (LNPs) rely on cationic ionizable lipids that carry a positive charge at a pH of approximately 7.4, triggering aggressive pro-inflammatory responses and complement activation.  UC Berkeley researchers have developed a novel class of lipids engineered to resolve the "charge-toxicity" trade-off in nucleic acid delivery. Unlike conventional ionizable lipids that maintain a problematic positive charge density at physiological levels, these quaternized ionizable lipids are specifically tuned to remain neutral or negatively charged at a pH of approximately 7.4. They only transition to a positively charged state in acidic environments, such as the endosome, ensuring that the payload is released exactly where it is needed without alerting the immune system during systemic circulation. 

Methionine (Met) is a common amino acid found in almost all proteins. When it undergoes oxidation (a common process in aging and disease), it transforms into methionine sulfoxide (Met-SO).The challenge is that this chemical reaction creates a new chiral center at the sulfur atom. This means that for every oxidized methionine, two different mirror-image versions (diastereomers) can exist: The (S,S) form and the (S,R) form.Before this invention, researchers struggled to separate these two forms. This resulted in two major technical hurdles:Standard techniques like High Performance Liquid Chromatography (HPLC) or fractional crystallization (a method dating back to 1947) were unreliable, difficult to reproduce, and failed to produce high-purity samplesBecause the two forms were so difficult to separate, almost all previous research on methionine oxidation used a mixture of both. This meant that if one form was toxic and the other was harmless, the results would be averaged out, hiding the true biological mechanism.A core motivation for this invention is the "staggering degree of disagreement" in Alzheimer's Disease research regarding the protein Amyloid beta (Aβ42)Some studies claimed that oxidized Aβ42 increased brain plaque toxicity, while others claimed it decreased itIt is plausible that these contradictions exist because previous researchers didn't know which specific diastereomer—(S,S) or (S,R)—they were testinOnce these two forms are created, they are remarkably stable. The energy barrier to flip from one form to the other is roughly 45.2 kcal/mol, which is significantly higher than other enantiomeric structures. This means that in the human body, the "wrong" version won't just flip back to the "right" one; it stays in that specific shape, potentially causing long-term damage if not properly regulated by specific enzymes (reductases). 

Comprehensive radiation detection across the spectral range requires distinct systems for ionizing and non-ionizing imaging because each technology faces unique architectural hurdles. Modern visible light detection has successfully transitioned from passive plates to digital Active Pixel Sensors (APS) by leveraging Complementary Metal-Oxide-Semiconductor (CMOS) technology to provide every pixel with its own dedicated amplifier and active circuitry. Ionizing radiation detection like X-ray and gamma-ray has relied on exotic scintillators to convert radiation into light, a process prone to lateral light scattering and degraded spatial resolution. Recent advancements in ionizing radiation have shifted toward direct conversion materials like amorphous selenium (a-Se), which transform X-rays directly into electrical charges. However, these direct-conversion devices do not scale to larger areas without significant noise being a factor. This is primarily due to thin-film transistor (TFT) backplanes which, unlike their CMOS counterparts, lack the local amplification necessary to maintain a high signal-to-noise ratio.

Reactive oxygen species (ROS), including hydrogen peroxide and peroxynitrite, play dual roles as essential signaling molecules and high-stress markers of cellular damage. However, imaging these volatile species in live biological systems is often hindered by diffusion and poor signal localization. Researchers at UC Berkeley have developed a "tandem" activity-based sensing and labeling strategy that overcomes these challenges. This technology utilizes selective chemical probes that, upon reacting with a specific ROS, undergo a transformation that simultaneously triggers a fluorescent signal and anchors the probe to nearby cellular proteins. By "trapping" the signal at the site of its production, this dual-action mechanism allows for high-resolution, localized imaging of oxidative stress and signaling events within complex cellular environments.

Glaucoma remains a leading cause of irreversible blindness worldwide, primarily due to the progressive degeneration of retinal ganglion cells. While traditional treatments focus on reducing intraocular pressure, they often fail to stop the underlying neurodegenerative process. UC Berkeley researchers have developed a novel neuroprotective strategy that involves modulating the activity of ocular serpinA3. By administering a serpinA3 polypeptide or a nucleic acid encoding the polypeptide directly to the eye, this technology aims to shield ocular tissues from damage and preserve visual function. This approach represents a significant shift toward directly protecting the nervous system of the eye, offering hope for patients who continue to lose vision despite controlled eye pressure.

Achieving a balance between high toughness and elasticity in polymer science is traditionally difficult, as increasing one property often compromises the other. To overcome this limitation, researchers at UC Berkeley have developed a method using crystalline woven and interlocked covalent organic frameworks (COFs) as structural additives. By incorporating these molecularly "woven" frameworks into polymer matrices, the resulting composite materials benefit from the unique mechanical energy dissipation provided by the interlocked COF threads. This molecular weaving approach allows for the creation of advanced materials that possess exceptional strength and flexibility, far surpassing the mechanical performance of standard polymers.